These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dogs infected with the blood trypomastigote form of Trypanosoma cruzi display an increase expression of cytokines and chemokines plus an intense cardiac parasitism during acute infection. de Souza SM; Vieira PM; Roatt BM; Reis LE; da Silva Fonseca K; Nogueira NC; Reis AB; Tafuri WL; Carneiro CM Mol Immunol; 2014 Mar; 58(1):92-7. PubMed ID: 24317279 [TBL] [Abstract][Full Text] [Related]
5. Enalapril prevents cardiac immune-mediated damage and exerts anti-Trypanosoma cruzi activity during acute phase of experimental Chagas disease. de Paula Costa G; Silva RR; Pedrosa MC; Pinho V; de Lima WG; Teixeira MM; Bahia MT; Talvani A Parasite Immunol; 2010 Mar; 32(3):202-8. PubMed ID: 20398183 [TBL] [Abstract][Full Text] [Related]
6. Concomitant exercise training attenuates the cardioprotective effects of pharmacological therapy in a murine model of acute infectious myocarditis. Mendonça AAS; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Talvani A; Natali AJ; Novaes RD Life Sci; 2019 Aug; 230():141-149. PubMed ID: 31129142 [TBL] [Abstract][Full Text] [Related]
7. 5-Lipoxygenase plays a role in the control of parasite burden and contributes to oxidative damage of erythrocytes in murine Chagas' disease. Borges CL; Cecchini R; Tatakihara VL; Malvezi AD; Yamada-Ogatta SF; Rizzo LV; Pinge-Filho P Immunol Lett; 2009 Mar; 123(1):38-45. PubMed ID: 19428550 [TBL] [Abstract][Full Text] [Related]
8. Concomitant Benznidazole and Suramin Chemotherapy in Mice Infected with a Virulent Strain of Trypanosoma cruzi. Santos EC; Novaes RD; Cupertino MC; Bastos DS; Klein RC; Silva EA; Fietto JL; Talvani A; Bahia MT; Oliveira LL Antimicrob Agents Chemother; 2015 Oct; 59(10):5999-6006. PubMed ID: 26169419 [TBL] [Abstract][Full Text] [Related]
10. Modulation of inflammatory response and parasitism by 15-Deoxy-Δ(12,14) prostaglandin J(2) in Trypanosoma cruzi-infected cardiomyocytes. Hovsepian E; Mirkin GA; Penas F; Manzano A; Bartrons R; Goren NB Int J Parasitol; 2011 Apr; 41(5):553-62. PubMed ID: 21215746 [TBL] [Abstract][Full Text] [Related]
11. Could pre-infection exercise training improve the efficacy of specific antiparasitic chemotherapy for Chagas disease? Santos EG; Gonçalves RV; Souza-Silva TG; Maldonado IRSC; Santos EC; Talvani A; Natali AJ; Novaes RD Parasitology; 2019 Nov; 146(13):1655-1664. PubMed ID: 31362797 [TBL] [Abstract][Full Text] [Related]
12. Cytokine modulation, oxidative stress and thymic dysfunctions: Role of age-related changes in the experimental Trypanosoma cruzi infection: Age-related thymic dysfunctions and Trypanosoma cruzi infection. Colato RP; Brazão V; do Vale GT; Santello FH; Sampaio PA; Tirapelli CR; Pereira-da-Silva G; Do Prado JC Cytokine; 2018 Nov; 111():88-96. PubMed ID: 30130728 [TBL] [Abstract][Full Text] [Related]
13. Effects of vitamin C supplementation on acute phase Chagas disease in experimentally infected mice with Trypanosoma cruzi QM1 strain. Marim RG; Gusmão AS; Castanho RE; Deminice R; Therezo AL; Jordão Júnior AA; Martins LP Rev Inst Med Trop Sao Paulo; 2012 Dec; 54(6):319-23. PubMed ID: 23152316 [TBL] [Abstract][Full Text] [Related]
14. Parasite control and skeletal myositis in Trypanosoma cruzi-infected and exercised rats. Novaes RD; Gonçalves RV; Penitente AR; Cupertino MC; Maldonado IRSC; Talvani A; Natali AJ Acta Trop; 2017 Jun; 170():8-15. PubMed ID: 28223068 [TBL] [Abstract][Full Text] [Related]
15. PPARγ ligand treatment inhibits cardiac inflammatory mediators induced by infection with different lethality strains of Trypanosoma cruzi. Penas F; Mirkin GA; Hovsepian E; Cevey A; Caccuri R; Sales ME; Goren NB Biochim Biophys Acta; 2013 Jan; 1832(1):239-48. PubMed ID: 22917565 [TBL] [Abstract][Full Text] [Related]
16. Impact of diminazene aceturate on renin-angiotensin system, infectious myocarditis and skeletal myositis in mice: An in vitro and in vivo study. Souza-Silva TG; Vilas-Boas DF; Gonçalves-Santos E; Mazzeti AL; Caldas IS; Gonçalves RV; Diniz LF; Novaes RD Life Sci; 2020 Sep; 257():118067. PubMed ID: 32652140 [TBL] [Abstract][Full Text] [Related]
17. Involvement of nitric oxide (NO) and TNF-alpha in the oxidative stress associated with anemia in experimental Trypanosoma cruzi infection. Malvezi AD; Cecchini R; de Souza F; Tadokoro CE; Rizzo LV; Pinge-Filho P FEMS Immunol Med Microbiol; 2004 May; 41(1):69-77. PubMed ID: 15094169 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of antioxidant therapy in experimental Chagas disease. Tieghi TM; Manca CC; Garcia LCT; Castanho REP; Therezo ALS; Frei F; Taipeiro EF; Martins LPA Rev Soc Bras Med Trop; 2017; 50(2):184-193. PubMed ID: 28562754 [TBL] [Abstract][Full Text] [Related]
19. EFFECTS OF VITAMIN C SUPPLEMENTATION ON THE CHRONIC PHASE OF CHAGAS DISEASE. Marim RG; de Gusmão AS; Castanho RE; Deminice R; Therezo AL; Jordão Júnior AA; de Assis MR; Taipeiro Ede F; Martins LP Rev Inst Med Trop Sao Paulo; 2015; 57(3):245-50. PubMed ID: 26200966 [TBL] [Abstract][Full Text] [Related]
20. Timing of expression of inflammatory mediators in skeletal muscles from mice acutely infected with the RA strain of Trypanosoma cruzi. Cutrullis RA; Postan M; Petray PB; Corral RS Pathobiology; 2009; 76(4):170-80. PubMed ID: 19571606 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]